Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 226 results found. Search for [ remdesivir ]

Results 1 to 21 of 226
PTI
August 8, 2020
The drug is being made available to over 1,000 hospitals providing COVID-19 treatment in India through the company's distribution network, Jubilant Life Sciences said in a statement


Reuters
August 7, 2020
The company will supply the first batches of the antiviral drug \"soon,\" and Gilead is expected to distribute the treatment, which was the first to be greenlit for the illness caused by the new coronavirus


BusinessToday.In
August 4, 2020
Stocks to watch today on August 4: Yes Bank, Jubilant Life, Exide, Bank of India, Dhanlaxmi Bank among others are the top stocks to watch out for in Tuesday's trading session.


PTI
August 4, 2020
On July 20, 2020, the company received approval from the Drug Controller General of India (DCGI) to manufacture and market remdesivir for 100 mg/vial (lyophilized injection) for restricted emergency use in India for the treatment of severe COVID-19


Reuters
July 31, 2020
The indictment states the Chinese hackers \"conducted reconnaissance\" against the computer network of a Massachusetts biotech firm known to be working on a coronavirus vaccine in January


Reuters
July 31, 2020
Gilead's second-quarter sales fell nearly 10% from a year earlier to $5.1 billion, short of the average analyst estimate of $5.3 billion, according to Refinitiv


BusinessToday.In
July 29, 2020
Dr Reddy's Laboratories stock rose up to 7.01% to the intraday high of Rs 4,334 compared to the previous close of Rs 4,050 on BSE


E Kumar Sharma
July 29, 2020
With this, close to 10 players -- Glenmark, Cipla and Dr Reddy's and others -- are either in the market or soon to launch. Currently, the drug is being sold in prices ranging between Rs 39 and Rs 75 per tablet for 200mg


Reuters
July 29, 2020
Drug, priced at Rs 59 per tablet, is approved to treat mild to moderate COVID-19 and will be available at drug stores from Wednesday, says Hetero


Prasanna Mohanty
July 27, 2020
Profit-driven enterprises are ill-suited to protect the health and life of a vast majority of people, as the US and Indian governments experience, but do precious little, thereby failing in their primary duty


BusinessToday.In
July 27, 2020
Avra Lab has developed an alternative low-cost and highly efficient manufacturing process and is now supplying commercial quantities to Cipla for the launch of Ciplenza, the generic version of Favipiravir


BusinessToday.In
July 24, 2020
Favipiravir, which is used to treat mild to moderate COVID-19 patients, will be commercially launched under the brand name Ciplenza in the first week of August, priced at Rs 68 per tablet


BusinessToday.In
July 22, 2020
Coronavirus treatment: Patients who were administered Glenmark's FabiFlu saw 40 per cent faster achievement of clinical cure


PTI
July 22, 2020
By understanding risk profiles and learning how to treat the disease, we've been able to greatly reduce mortality in the United States, Trump said


Reuters
July 22, 2020
In results announced last month, a trial by researchers in the United Kingdom showed dexamethasone as the first drug to save lives of COVID-19 patients in what scientists said was a major breakthrough in the coronavirus pandemic


PB Jayakumar
July 21, 2020
Glenmark says compared to other therapies approved for emergency use in COVID-19 in India, FabiFlu is much more economical and an effective treatment option; DCGI had earlier asked it to clarify on allegation that the drug was unaffordable due to its high pricing


BusinessToday.In
July 21, 2020
The pharma share gained up to 4.44% to Rs 753.4 against previous close of Rs 721.50 on BSE


BusinessToday.In
July 21, 2020
Stocks to watch today on July 21: IndiGo, SBI Cards, ACC, Indian Oil, Jubilant Life among others are the top stocks to watch out for in Tuesday's trading session.


BusinessToday.In
July 20, 2020
Remdesivir is one of the few medicines believed to be effective in treating coronavirus patients. So far, it has secured approvals for emergency use from US FDA and conditional approval from the European Commission.


Associated Press
July 20, 2020
For months before studies like these, learning what helps or harms has been undermined by \"desperation science\" as doctors and patients tried therapies on their own or through a host of studies not strong enough to give clear answers


PAGES 1 OF 12  12345